News
Results were announced from a phase 3 trial evaluating solriamfetol for major depressive disorder with/without severe excessive daytime sleepiness.
7d
News-Medical.Net on MSNLithium shifts circadian rhythms early in bipolar disorder and may offer clues to treatment responseA randomized controlled trial shows that lithium treatment in bipolar disorder patients reduces daytime activity, advances ...
HuffPost on MSN6d
Doctors Are Begging Everyone To Learn These Menopause Facts That Most People Are Somehow Completely Clueless AboutWhen it comes to women’s health, there are many topics that aren’t discussed as often as they should be — or discussed ...
Bright Minds Biosciences has a decent balance sheet, with roughly $40.3 million in cash. Click here to find out why I rate ...
The We Defy Foundation is celebrating 10 years of fulfilling their mission of providing therapeutic relief for disabled ...
April 2025 presents Scorpio with a transformative month, emphasizing resolution of past complications, strategic career ...
Porsha’s birthday trip turns chaotic as Angela invites Drew, sparking tension, confessions, and scandal on the Real ...
13h
Mongabay News on MSN15 years after the BP oil spill disaster, how is the Gulf of Mexico faring?Down past New Orleans lies Plaquemines parish, a narrow sliver of land at the tip of Louisiana that reaches southward like a ...
The largest planned development in the area is the mixed-use Village Center project ... sense of awareness of what’s going on ...
11d
Cryptopolitan on MSNDOGE Price on the Brink: Analysts See Drop Below $0.10 in June as XYZVerse (XYZ) Poised to Capture 80% of Crypto Holders by 2026Dogecoin may be heading towards a sharp price drop, with analysts forecasting it could slip below ten cents in June due to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results